Suppr超能文献

叉头框蛋白 P3 调节性 T 细胞与癌相关成纤维细胞共存与肺腺癌不良预后相关。

Forkhead box P3 regulatory T cells coexisting with cancer associated fibroblasts are correlated with a poor outcome in lung adenocarcinoma.

机构信息

Division of Pathology, Research Center for Innovative Oncology, Chiba, Japan.

出版信息

Cancer Sci. 2013 Apr;104(4):409-15. doi: 10.1111/cas.12099. Epub 2013 Feb 19.

Abstract

Recently, an association between tumor infiltrating Forkhead box P3 regulatory T cells (Treg ) and an unfavorable prognosis has been clinically shown in some cancers, but the mechanism of Treg induction in the tumor microenvironment remains uncertain. The aims of the present study were to examine the relationship between Treg and patient outcome and to investigate whether Treg induction is influenced by the characteristics of cancer-associated fibroblasts (CAF) in lung adenocarcinoma. The numbers of Treg in both the tumor stroma and the tumor nest were counted in 200 consecutive pathological stage I lung invasive adenocarcinoma specimens. To examine whether the characteristics of CAF influence Treg induction, we selected and cultured CAF from low Treg and high Treg adenocarcinoma. The number of Treg was much higher in the stroma than in the nest (P < 0.01). Patients with high Treg had a significantly poorer prognosis than those with low Treg (overall survival: P = 0.03; recurrence-free survival: P = 0.02; 5-year overall survival: 85.4% vs 93.0%). Compared with the CAF from low Treg adenocarcinoma, culture supernatant of the CAF from high Treg adenocarcinoma induced more Treg (P = 0.01). Also, CAF from high Treg adenocarcinoma expressed significantly higher mRNA levels of transforming growth factor-β (P = 0.01) and vascular endothelial growth factor (P = 0.01), both of which are involved in Treg induction. Our studies suggest the possibility that CAF expressing immunoregulatory cytokines may induce Treg in the stroma, creating a tumor-promoting microenvironment in lung adenocarcinoma that leads to a poor outcome.

摘要

最近,一些癌症的临床研究表明,肿瘤浸润性叉头框 P3 调节性 T 细胞(Treg)与不良预后相关,但 Treg 在肿瘤微环境中的诱导机制仍不确定。本研究旨在探讨 Treg 与患者预后的关系,并研究 Treg 的诱导是否受肺癌中癌相关成纤维细胞(CAF)特征的影响。在 200 例连续的病理 I 期肺浸润性腺癌标本中,计数肿瘤基质和肿瘤巢中 Treg 的数量。为了研究 CAF 的特征是否影响 Treg 的诱导,我们从低 Treg 和高 Treg 腺癌中选择和培养 CAF。基质中 Treg 的数量明显高于巢内(P<0.01)。高 Treg 患者的总生存期(P=0.03)和无复发生存期(P=0.02)明显差于低 Treg 患者,5 年总生存率为 85.4%比 93.0%。与低 Treg 腺癌的 CAF 相比,高 Treg 腺癌 CAF 的培养上清液诱导的 Treg 更多(P=0.01)。此外,高 Treg 腺癌的 CAF 表达更高水平的转化生长因子-β(P=0.01)和血管内皮生长因子(P=0.01)mRNA,这两者都参与 Treg 的诱导。我们的研究表明,表达免疫调节细胞因子的 CAF 可能在基质中诱导 Treg,在肺腺癌中形成促进肿瘤的微环境,导致不良预后。

相似文献

2
4
Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer.
Cancer Cell. 2018 Mar 12;33(3):463-479.e10. doi: 10.1016/j.ccell.2018.01.011. Epub 2018 Feb 15.
5
Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells.
Lung Cancer. 2012 Jan;75(1):95-101. doi: 10.1016/j.lungcan.2011.06.002. Epub 2011 Jun 29.
7
Characterization of the tumor immune-microenvironment of lung adenocarcinoma associated with usual interstitial pneumonia.
Lung Cancer. 2018 Dec;126:162-169. doi: 10.1016/j.lungcan.2018.11.006. Epub 2018 Nov 6.
9
Link between tumor-promoting fibrous microenvironment and an immunosuppressive microenvironment in stage I lung adenocarcinoma.
Lung Cancer. 2018 Dec;126:64-71. doi: 10.1016/j.lungcan.2018.10.021. Epub 2018 Oct 28.
10
Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers.
Nat Med. 2016 Jun;22(6):679-84. doi: 10.1038/nm.4086. Epub 2016 Apr 25.

引用本文的文献

2
The Current State of Tumor Microenvironment-Specific Therapies for Non-Small Cell Lung Cancer.
Cancers (Basel). 2025 May 22;17(11):1732. doi: 10.3390/cancers17111732.
4
7
Influencing factors and solution strategies of chimeric antigen receptor T-cell therapy (CAR-T) cell immunotherapy.
Oncol Res. 2024 Aug 23;32(9):1479-1516. doi: 10.32604/or.2024.048564. eCollection 2024.
8
MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer.
Signal Transduct Target Ther. 2024 Aug 21;9(1):205. doi: 10.1038/s41392-024-01907-z.
9
Comprehensive bioinformatics analysis of human cytomegalovirus pathway genes in pan-cancer.
Hum Genomics. 2024 Jun 17;18(1):65. doi: 10.1186/s40246-024-00633-5.
10
Cancer-associated fibroblasts: heterogeneity and their role in the tumor immune response.
Clin Exp Med. 2024 Jun 12;24(1):126. doi: 10.1007/s10238-024-01375-3.

本文引用的文献

2
Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells.
Lung Cancer. 2012 Jan;75(1):95-101. doi: 10.1016/j.lungcan.2011.06.002. Epub 2011 Jun 29.
3
Podoplanin-positive fibroblasts enhance lung adenocarcinoma tumor formation: podoplanin in fibroblast functions for tumor progression.
Cancer Res. 2011 Jul 15;71(14):4769-79. doi: 10.1158/0008-5472.CAN-10-3228. Epub 2011 May 24.
4
Prognostic significance of a solid component in pulmonary adenocarcinoma.
Ann Thorac Surg. 2011 Apr;91(4):1051-7. doi: 10.1016/j.athoracsur.2010.11.071.
7
FOXP3+ regulatory T cells in the human immune system.
Nat Rev Immunol. 2010 Jul;10(7):490-500. doi: 10.1038/nri2785. Epub 2010 Jun 18.
9
Cancer associated fibroblasts (CAFs) in tumor microenvironment.
Front Biosci (Landmark Ed). 2010 Jan 1;15(1):166-79. doi: 10.2741/3613.
10
Cancer statistics, 2009.
CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49. doi: 10.3322/caac.20006. Epub 2009 May 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验